Lizozomal Depo Hastalıkları ve Görüntüleme Bulguları

Parenti G, Andria G, Ballabio A. Lysosomal storage diseases: from pathophysiology to therapy. Annu Rev Med. 2015 Jan 14;66:471–86.

İnci A. Lizozomal Depo Hastalığı Gelişiminde Rolü Olan Yeni Mekanizmalar ve Depolanma Dışında Etkilenen Diğer Mekanizmalar. In: Tümer L, editor. Lizozomal Hastalıkların Tanı ve Tedavisinde Yenilikler. 1st ed. Ankara: Türkiye Klinikleri; 2021. p. 1–7.

Platt FM, d’Azzo A, Davidson BL, Neufeld EF, Tifft CJ. Lysosomal storage diseases. Nat Rev Dis Primers. 2018 Dec 1;4(1).

Schultz ML, Tecedor L, Chang M, Davidson BL. Clarifying lysosomal storage diseases. Vol. 34, Trends in Neurosciences. 2011. p. 401–10.

Wang M, Li F, Zhang J, Lu C, Kong W. Global Epidemiology of Gaucher Disease: an Updated Systematic Review and Meta-analysis. J Pediatr Hematol Oncol. 2023 May 1;45(4):181.

Rajkumar V, Dumpa V. Lysosomal Storage Disease. [Updated 2023 Jul 24]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-.

Vanier MT, Caillaud C, Levade T. Inborn Metabolic Diseases. 7th ed. Saudubray JM, Baumgartner MR, Garcia-Cazorla A, Walter JH, editor. Berlin: Springer; 2022. p.735–761.

Kılıç M. Lizozomal Depo Hastalıkları. In: ’Yurdakök M, editor. Yurdakök Pediatri. Ankara: Güneş Tıp Kitabevleri; 2018. p. 227–49.

Sun A. Lysosomal storage disease overview. Ann Transl Med. 2018 Dec;6(24):476.-476.

Verity CM, Winstone AM, Stellitano L, Will R, Nicoll A. The epidemiology of progressive intellectual and neurological deterioration in childhood. Arch Dis Child. 2010 May;95(5):361–4.

Biswas A, Malhotra M, Mankad K, Carney O, Darco F, Muthusamy K, et al. Clinico-radiological phenotyping and diagnostic pathways in childhood neurometabolic disorders—a practical introductory guide. Transl Pediatr. 2021;10(4):1201–30.

Karimzadeh P, Ghofrani M, Nasiri S. Approach to Patients with Neurometabolic Diseases Who Show Characteristic Signs and Symptoms. Vol. 14, Iran J Child Neurol. Summer. 2020.

Öktem RM, Biberoğlu G. Tanıda Yenilikler: Biyobelirteçler ve Tarama Testleri. In: Tümer L, editor. Lizozomal Hastalıkların Tanı ve Tedavisinde Yenilikler. 1st ed. Ankara: TürkiyeKlinikleri; 2021. p. 8–15.

Kuchař L, Ledvinová J, Hřebíček M, Myšková H, Dvořáková L, Berná L, et al. Prosaposin Deficiency and Saposin B Deficiency (Activator-Deficient Metachromatic Leukodystrophy): Report on Two Patients Detected by Analysis of Urinary Sphingolipids and Carrying Novel PSAP Gene Mutations. Am J Med Genet A. 2009;149A(4):613.

Spiegel R, Bach G, Sury V, Mengistu G, Meidan B, Shalev S, et al. A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. Mol Genet Metab. 2005 Feb;84(2):160–6.

Cesani M, Lorioli L, Grossi S, Amico G, Fumagalli F, Spiga I, et al. Mutation Update of ARSA and PSAP Genes Causing Metachromatic Leukodystrophy. Hum Mutat. 2016 Jan 1;37(1):16–27.

Tamargo RJ, Velayati A, Goldin E, Sidransky E. The role of saposin C in Gaucher disease. Mol Genet Metab. 2012 Jul;106(3):257–63.

Jones S, Wijburg FA. Inborn Metabolic Diseases. 7th ed. Saudubray JM, Baumgartner MR, Garcia-Cazorla A, Walter JH, editor. Berlin: Springer; 2022. 765–780 p.

Parker EI, Xing M, Moreno-De-Luca A, Harmouche E, Terk MR. Radiological and clinical characterization of the lysosomal storage disorders: non-lipid disorders. Br J Radiol. 2014 Jan;87(1033):20130467

D'Arco F, Hanagandi P, Ganau M, Krishnan P, Taranath A. Neuroimaging Findings in Lysosomal Disorders: 2018 Update. Top Magn Reson Imaging. 2018 Aug;27(4):259-274.

Fratantoni JC, Hall CW, Neufeld EF. Hurler and Hunter syndromes: mutual correction of the defect in cultured fibroblasts. Science. 1968;162(3853):570–2.

Ezgü FS. Lizozomal Hastalıklarda Gen Tedavisi. In: Tümer L, editor. Lizozomal Hastalıkların Tanı ve Tedavisinde Yenilikler. 1st ed. Ankara: Türkiye Klinikleri; 2021. p. 43–6.

Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, et al. Replacement Therapy for Inherited Enzyme Deficiency--Macrophage-Targeted Glucocerebrosidase for Gaucher’s Disease. New England Journal of Medicine. 1991 May 23;324(21):1464–70.

Concolino D, Deodato F, Parini R. Enzyme replacement therapy: efficacy and limitations. Ital J Pediatr. 2018 Nov 16;44(Suppl 2):120.

Kishnani PS, Dickson PI, Muldowney L, Lee JJ, Rosenberg A, Abichandani R, et al. Immune response to enzyme replacement therapies in lysosomal storage diseases and the role of immune tolerance induction. Mol Genet Metab. 2016 Feb 1;117(2):66–83.

McCafferty EH, Scott LJ. Migalastat: A Review in Fabry Disease. Drugs. 2019 Apr 1;79(5):543.

Blair HA. Cipaglucosidase Alfa: First Approval. Drugs. 2023 Jun 1;83(8):739.

Mengel E, Patterson MC, Da Riol RM, Del Toro M, Deodato F, Gautschi M, et al. Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment. J Inherit Metab Dis. 2021 Nov 1;44(6):1463.

Tan EY, Boelens JJ, Jones SA, Wynn RF. Hematopoietic Stem Cell Transplantation in Inborn Errors of Metabolism. Front Pediatr. 2019 Oct 25;7:433.

Page KM, Stenger EO, Connelly JA, Shyr D, West T, Wood S, et al. Hematopoietic Stem Cell Transplantation to Treat Leukodystrophies: Clinical Practice Guidelines from the Hunter’s Hope Leukodystrophy Care Network. Biology of Blood and Marrow Transplantation. 2019 Dec 1;25(12):e363–74.

Kubaski F, Yabe H, Suzuki Y, Seto T, Hamazaki T, Mason RW, et al. Hematopoietic Stem Cell Transplantation for Patients with Mucopolysaccharidosis II. Biol Blood Marrow Transplant. 2017 Oct 1;23(10):1795.

Chakraborty S, Gupta AK, Gupta N, Meena JP, Seth R, Kabra M. Hematopoietic Stem Cell Transplantation for Storage Disorders: Present Status. Indian J Pediatr. 2024 Aug 1;91(8):830–8.

Aldenhoven M, Wynn RF, Orchard PJ, O’Meara A, Veys P, Fischer A, et al. Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study. Blood. 2015 Mar 26;125(13):2164–72.

Ferreira CR, Gahl WA. Lysosomal Storage Disease. Metabolic Diseases: Foundations of Clinical Management, Genetics, and Pathology. 2023 Jul 24;367–440.

Kido J, Sugawara K, Nakamura K. Gene therapy for lysosomal storage diseases: Current clinical trial prospects. Front Genet. 2023 Jan 13;14:1064924.

Marques ARA, Saftig P. Lysosomal storage disorders – challenges, concepts and avenues for therapy: Beyond rare diseases. J Cell Sci. 2019 Jan 1;132(2).